These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 31935471

  • 1. Development of inhalable quinacrine loaded bovine serum albumin modified cationic nanoparticles: Repurposing quinacrine for lung cancer therapeutics.
    Vaidya B, Kulkarni NS, Shukla SK, Parvathaneni V, Chauhan G, Damon JK, Sarode A, Garcia JV, Kunda N, Mitragotri S, Gupta V.
    Int J Pharm; 2020 Mar 15; 577():118995. PubMed ID: 31935471
    [Abstract] [Full Text] [Related]

  • 2. Development of pharmaceutically scalable inhaled anti-cancer nanotherapy - Repurposing amodiaquine for non-small cell lung cancer (NSCLC).
    Parvathaneni V, Kulkarni NS, Chauhan G, Shukla SK, Elbatanony R, Patel B, Kunda NK, Muth A, Gupta V.
    Mater Sci Eng C Mater Biol Appl; 2020 Oct 15; 115():111139. PubMed ID: 32600728
    [Abstract] [Full Text] [Related]

  • 3. Nanotechnology Based Repositioning of an Anti-Viral Drug for Non-Small Cell Lung Cancer (NSCLC).
    Parvathaneni V, Goyal M, Kulkarni NS, Shukla SK, Gupta V.
    Pharm Res; 2020 Jun 08; 37(7):123. PubMed ID: 32514688
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Repurposing Quinacrine for Treatment of Malignant Mesothelioma: In-Vitro Therapeutic and Mechanistic Evaluation.
    Kulkarni NS, Vaidya B, Parvathaneni V, Bhanja D, Gupta V.
    Int J Mol Sci; 2020 Aug 31; 21(17):. PubMed ID: 32878257
    [Abstract] [Full Text] [Related]

  • 10. Nano-synergistic combination of Erlotinib and Quinacrine for non-small cell lung cancer (NSCLC) therapeutics - Evaluation in biologically relevant in-vitro models.
    Kulkarni NS, Vaidya B, Gupta V.
    Mater Sci Eng C Mater Biol Appl; 2021 Feb 31; 121():111891. PubMed ID: 33579503
    [Abstract] [Full Text] [Related]

  • 11. Afatinib-loaded inhalable PLGA nanoparticles for localized therapy of non-small cell lung cancer (NSCLC)-development and in-vitro efficacy.
    Elbatanony RS, Parvathaneni V, Kulkarni NS, Shukla SK, Chauhan G, Kunda NK, Gupta V.
    Drug Deliv Transl Res; 2021 Jun 31; 11(3):927-943. PubMed ID: 32557351
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cholesterol-conjugated bovine serum albumin nanoparticles as a tamoxifen tumor-targeted delivery system.
    Gharbavi M, Johari B, Eslami SS, Mousazadeh N, Sharafi A.
    Cell Biol Int; 2020 Dec 31; 44(12):2485-2498. PubMed ID: 32841441
    [Abstract] [Full Text] [Related]

  • 14. Development and characterization of inhalable transferrin functionalized amodiaquine nanoparticles - Efficacy in Non-Small Cell Lung Cancer (NSCLC) treatment.
    Parvathaneni V, Shukla SK, Kulkarni NS, Gupta V.
    Int J Pharm; 2021 Oct 25; 608():121038. PubMed ID: 34438008
    [Abstract] [Full Text] [Related]

  • 15. Bovine serum albumin adsorbed PGA-co-PDL nanocarriers for vaccine delivery via dry powder inhalation.
    Kunda NK, Alfagih IM, Dennison SR, Tawfeek HM, Somavarapu S, Hutcheon GA, Saleem IY.
    Pharm Res; 2015 Apr 25; 32(4):1341-53. PubMed ID: 25297713
    [Abstract] [Full Text] [Related]

  • 16. Oral inhalation of dacomitinib nanocarriers as a therapeutic strategy for non-small cell lung cancer.
    Rongala DS, Patil SM, Kunda NK.
    Nanomedicine (Lond); 2024 Apr 25; 19(18-20):1601-1613. PubMed ID: 39073842
    [Abstract] [Full Text] [Related]

  • 17. Dry powder pulmonary delivery of cationic PGA-co-PDL nanoparticles with surface adsorbed model protein.
    Kunda NK, Alfagih IM, Dennison SR, Somavarapu S, Merchant Z, Hutcheon GA, Saleem IY.
    Int J Pharm; 2015 Aug 15; 492(1-2):213-22. PubMed ID: 26169146
    [Abstract] [Full Text] [Related]

  • 18. Development of an inhalable, stimuli-responsive particulate system for delivery to deep lung tissue.
    Abbas Y, Azzazy HM, Tammam S, Lamprecht A, Ali ME, Schmidt A, Sollazzo S, Mathur S.
    Colloids Surf B Biointerfaces; 2016 Oct 01; 146():19-30. PubMed ID: 27244047
    [Abstract] [Full Text] [Related]

  • 19. A Comparative Study of Orally Delivered PBCA and ApoE Coupled BSA Nanoparticles for Brain Targeting of Sumatriptan Succinate in Therapeutic Management of Migraine.
    Girotra P, Singh SK.
    Pharm Res; 2016 Jul 01; 33(7):1682-95. PubMed ID: 27003706
    [Abstract] [Full Text] [Related]

  • 20. Bisphosphonate-coated BSA nanoparticles lack bone targeting after systemic administration.
    Wang G, Kucharski C, Lin X, Uludağ H.
    J Drug Target; 2010 Sep 01; 18(8):611-26. PubMed ID: 20158316
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.